Charlotta Hedner

700 total citations
21 papers, 440 citations indexed

About

Charlotta Hedner is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Charlotta Hedner has authored 21 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 11 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Charlotta Hedner's work include Esophageal Cancer Research and Treatment (12 papers), Gastric Cancer Management and Outcomes (10 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Charlotta Hedner is often cited by papers focused on Esophageal Cancer Research and Treatment (12 papers), Gastric Cancer Management and Outcomes (10 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Charlotta Hedner collaborates with scholars based in Sweden, Ireland and United Kingdom. Charlotta Hedner's co-authors include Karin Jirström, Björn Nodin, David Borg, Jakob Eberhard, Mathias Uhlén, Karin Leandersson, Alexander Gaber, Patrick Micke, Anders Johnsson and Anna Larsson and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Charlotta Hedner

18 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charlotta Hedner Sweden	13	236	155	148	141	134	21	440
Claire A. Margolis United States	7	217 0.9×	101 0.7×	232 1.6×	63 0.4×	147 1.1×	11	440
Xin-Ke Zhang China	7	215 0.9×	118 0.8×	65 0.4×	67 0.5×	78 0.6×	9	359
Zhongli Zhan China	11	178 0.8×	223 1.4×	78 0.5×	56 0.4×	62 0.5×	23	361
Aafke Creemers Netherlands	11	215 0.9×	140 0.9×	77 0.5×	125 0.9×	38 0.3×	16	353
Jieti Wang China	15	344 1.5×	147 0.9×	165 1.1×	62 0.4×	318 2.4×	24	582
Hanji Fang China	13	310 1.3×	123 0.8×	151 1.0×	62 0.4×	278 2.1×	20	509
S-A Im South Korea	5	246 1.0×	158 1.0×	75 0.5×	42 0.3×	73 0.5×	19	326
Jacob Elebro Sweden	14	345 1.5×	80 0.5×	155 1.0×	107 0.8×	108 0.8×	28	492
Sung Kim South Korea	11	171 0.7×	252 1.6×	159 1.1×	133 0.9×	40 0.3×	21	489
Andrej Valkov Norway	13	247 1.0×	231 1.5×	105 0.7×	24 0.2×	113 0.8×	14	406

Countries citing papers authored by Charlotta Hedner

Since Specialization

Citations

This map shows the geographic impact of Charlotta Hedner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotta Hedner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotta Hedner more than expected).

Fields of papers citing papers by Charlotta Hedner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotta Hedner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotta Hedner. The network helps show where Charlotta Hedner may publish in the future.

Co-authorship network of co-authors of Charlotta Hedner

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotta Hedner. A scholar is included among the top collaborators of Charlotta Hedner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotta Hedner. Charlotta Hedner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Παπαδάκος, Κωνσταντίνος Σ., Chrysostomi Gialeli, Charlotta Hedner, et al.. (2024). The prognostic and potentially immunomodulatory role of cartilage oligomeric matrix protein in patients with gastric and esophageal adenocarcinoma. Cancer Immunology Immunotherapy. 73(5). 93–93.

Nodin, Björn, David Borg, Charlotta Hedner, et al.. (2022). High Infiltration of CD68<sup>+</sup>/CD163<sup>−</sup> Macrophages Is an Adverse Prognostic Factor after Neoadjuvant Chemotherapy in Esophageal and Gastric Adenocarcinoma. Journal of Innate Immunity. 14(6). 615–628. 12 indexed citations

Sheehan, Katherine M., Elaine W. Kay, Charlotta Hedner, et al.. (2021). Development of a Novel Weighted Ranking Method for Immunohistochemical Quantification of a Heterogeneously Expressed Protein in Gastro-Esophageal Cancers. Cancers. 13(6). 1286–1286.

Borg, David, et al.. (2021). T cells, B cells, and PD-L1 expression in esophageal and gastric adenocarcinoma before and after neoadjuvant chemotherapy: relationship with histopathological response and survival. OncoImmunology. 10(1). 1921443–1921443. 18 indexed citations

Borg, David, Charlotta Hedner, Björn Nodin, et al.. (2020). Tumor-Associated CD68+, CD163+, and MARCO+ Macrophages as Prognostic Biomarkers in Patients With Treatment-Naïve Gastroesophageal Adenocarcinoma. Frontiers in Oncology. 10. 534761–534761. 28 indexed citations

Borg, David, Cheng Zhang, Charlotta Hedner, et al.. (2019). Expression of PD-L1 and PD-1 in Chemoradiotherapy-Naïve Esophageal and Gastric Adenocarcinoma: Relationship With Mismatch Repair Status and Survival. Frontiers in Oncology. 9. 136–136. 34 indexed citations

Borg, David, Anna Larsson, Charlotta Hedner, et al.. (2018). Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma. Journal of Translational Medicine. 16(1). 290–290. 7 indexed citations

Hedner, Charlotta, David Borg, Björn Nodin, et al.. (2017). Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment. Journal of Clinical Pathology. 71(5). 451–462. 9 indexed citations

Hedner, Charlotta, David Borg, Jakob Eberhard, et al.. (2017). The integrative clinical impact of tumor-infiltrating T lymphocytes and NK cells in relation to B lymphocyte and plasma cell density in esophageal and gastric adenocarcinoma. Oncotarget. 8(42). 72108–72126. 50 indexed citations

10.

Borg, David, Charlotta Hedner, Björn Nodin, et al.. (2016). Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma. BMC Clinical Pathology. 16(1). 13–13. 27 indexed citations

11.

Borg, David, Charlotta Hedner, Alexander Gaber, et al.. (2016). Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma. Biomarker Research. 4(1). 10–10. 26 indexed citations

12.

Hedner, Charlotta, David Borg, Björn Nodin, et al.. (2016). Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma. PLoS ONE. 11(2). e0148101–e0148101. 23 indexed citations

13.

Borg, David, Charlotta Hedner, Jonna Berntsson, et al.. (2016). Prognostic impact of tumour-associated B cells and plasma cells in oesophageal and gastric adenocarcinoma. Journal of Gastrointestinal Oncology. 7(6). 848–859. 43 indexed citations

14.

Hedner, Charlotta, David Borg, Björn Nodin, et al.. (2016). Prognostic impact of tumor-associated B-cells and plasma cells in esophageal and gastric adenocarcinoma.. Journal of Clinical Oncology. 34(4_suppl). 63–63.

15.

Hedner, Charlotta, Lena Tran, David Borg, et al.. (2015). Discordant human epidermal growth factor receptor 2 overexpression in primary and metastatic upper gastrointestinal adenocarcinoma signifies poor prognosis. Histopathology. 68(2). 230–240. 18 indexed citations

16.

Hedner, Charlotta, Alexander Gaber, Björn Nodin, et al.. (2014). SATB1 is an independent prognostic factor in radically resected upper gastrointestinal tract adenocarcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 465(6). 649–659. 25 indexed citations

17.

Gaber, Alexander, Charlotta Hedner, Björn Nodin, et al.. (2014). Expression and prognostic significance of the polymeric immunoglobulin receptor in esophageal and gastric adenocarcinoma. Journal of Translational Medicine. 12(1). 83–83. 38 indexed citations

18.

Hedner, Charlotta, Alexander Gaber, Björn Nodin, et al.. (2014). High expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death. Biomarker Research. 2(1). 11–11. 29 indexed citations

19.

Hedner, Charlotta, Pia C. Sundgren, & Aine Marie Kelly. (2013). Associations between Presence of Relevant Information in Referrals to Radiology and Prevalence Rates in Patients with Suspected Pulmonary Embolism. Academic Radiology. 20(9). 1115–1121. 7 indexed citations

20.

Nodin, Björn, Charlotta Hedner, Mathias Uhlén, & Karin Jirström. (2012). Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer. Journal of Ovarian Research. 5(1). 24–24. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact